ARCHIVES

Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89

This article is from The Cancer Letter archive.

Vol. 13 No. 29 | July 17, 1987

Download PDF Visit The Full Archive

Related Articles

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

September issue of Business & Regulatory Report included (8-page issue).

October 4, 2002

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

Kansas Gov. Sebelius Nominated For HHS

March 6, 2009

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

Health Policy: Organ Procurement Should Cover Wider Areas, IOM Report Says

August 6, 1999